Characterizing changes in kidney and renal pelvis cancer incidence from 1998 to 2006 in the United States.
In this study, we characterize the changes in kidney and renal pelvis cancer (RCC) from 1998 to 2006 in the United States. The goal is to examine variations in stage and treatments. In addition, we explore changes in risk factors that have occurred over the same period. Data on over 20,000 patients diagnosed with RCC in National Cancer Data Base were used for the study. We investigated the changes in stage and treatment rates based on race, gender and age at diagnosis from 1998 to 2006. Changes in smoking, obesity and hypertension rates over the period were examined for comparison. The increase in RCC incidence rates from 1998 to 2006 was almost entirely a result of increases in stage I. Increases for blacks were proportionally higher than whites. Obesity and hypertension increased over the period but smoking declined. In terms of treatment, there was an increase in surgery cases primarily for stage I. There were no significant differences in trends based on gender, although rates in men were 65% greater than in women. The mean age at diagnosis was stable for stages I-IV. There are increased incidences of renal tumors, particularly stage I renal cancer among blacks and whites from 1998 to 2006. Patients were more likely to undergo surgical therapy for these tumors.
Knox
Michael
M
University of Alabama at Birmingham, 1530 3rd Ave South, Birmingham, Al 35294, USA.
Colli
Janet L
JL
D000368:Aged; D002292:Carcinoma, Renal Cell / Q000453:epidemiology* / Q000473:pathology; D005260:Female; D006801:Humans; D015994:Incidence; D007680:Kidney Neoplasms / Q000453:epidemiology* / Q000473:pathology; D007682:Kidney Pelvis; D008297:Male; D009367:Neoplasm Staging; D012307:Risk Factors; D013997:Time Factors; D014481:United States / Q000453:epidemiology
Cancer Epidemiol Biomarkers Prev. 1996 Jan;5(1):17-21
8770461
Br J Urol. 1989 Feb;63(2):135-40
2702397
N Engl J Med. 1996 Nov 21;335(21):1552-8
8900087
J Urol. 2009 Oct;182(4):1271-9
19683266
Cancer Res. 1992 Jan 15;52(2):254-7
1728398
J Urol. 2006 Dec;176(6 Pt 1):2353-8
17085101
Urol Oncol. 2004 Nov-Dec;22(6):478-84
15610865
BJU Int. 2009 Apr;103(7):889-93
19021607
JAMA. 1999 May 5;281(17):1628-31
10235157
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
18287387
Hypertension. 2008 Nov;52(5):818-27
18852389
JAMA. 2003 Jul 9;290(2):199-206
12851274
Am J Epidemiol. 2000 Aug 1;152(3):272-8
10933274
Eur J Cancer Prev. 2002 Apr;11(2):171-8
11984136
Urology. 1998 Feb;51(2):203-5
9495698
Int J Cancer. 2006 Feb 1;118(3):728-38
16094628
Scand J Urol Nephrol. 2002;36(6):414-8
12623504
J Urol. 2008 May;179(5):1704-8
18343443
J Clin Oncol. 2007 Aug 20;25(24):3589-95
17704406